Randomized, Single-blind, Cross-over Study Investigating the Non-inferiority of Efficacy and Safety of HyQvia in Comparison With Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropathy

Trial Profile

Randomized, Single-blind, Cross-over Study Investigating the Non-inferiority of Efficacy and Safety of HyQvia in Comparison With Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropathy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Multifocal motor neuropathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 05 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
    • 24 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top